Endometrial Cancer
Women with endometrial cancer of high-intermediate risk, who comprise about 30% of the patient population, can be safely treated with vaginal brachytherapy (VBT) after surgery instead of undergoing external beam radiation therapy (EBRT). Both approaches offer similar control of recurrences and have a similar impact on survival, but VBT is associated with “significantly better” [...]
Screening for ovarian cancer in 2010- what should be done?
Ovarian cancer is a deadly disease. It is frequently diagnosed late when it has a high mortality rate. Early detection of this disease by screening is attractive as when the disease is diagnosed early, the prognosis is better. Two very large trials of different approaches to [...]
MODEST AND REAL OFFERS FOR MESOTHELIOMA
Physicians presenting clinical information at the Malignant Mesothelioma Conference, taken by the University of Chicago, echoed one and other with a recurring theme–while the past has offered little in the way of advancements in surgical, radiotherapy, and chemotherapy, new active drugs and insights into the biology of mesothelioma are showing [...]
Surgery Alone May Be Reasonable for Stage I Small-Cell Lung Cancer
An analysis of outcomes from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database indicates that surgery without radiotherapy for stage I small-cell lung cancer (SCLC) “appears to offer reasonable survival outcomes.” The findings led researchers to conclude that lobectomy by itself is a [...]
Cancer Pain is “Public Health Catastrophe” in Europe
Patient access to medication to relieve cancer pain is “profoundly restricted” in many European countries. The resulting undertreatment of cancer pain and the related suffering are a “public health catastrophe,” according to a new report. The problem is most prevalent in Eastern Europe, where a combination of misconceptions [...]
About Lung Cancer
Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs. These abnormal cells do not carry out the functions of normal cells and do not develop into healthy lung tissue. As they grow, the abnormal cells can form tumors and impede the function of the lung, which is to [...]
In The “Year Of The Lung,” Utah Company Freshmedx Announces Breakthrough Lung Cancer Diagnostic
In celebration of World Cancer Day and the Year of the Lung, Freshmedx today announced that it has entered into multiple discussions for the international license of its Bioconductance Scanning Platform (BSP). The BSP is a medical device that can dramatically improve [...]
